Sandra Jill James is an American biochemist and autism researcher who studies metabolic autism biomarkers. She is a member of the Autism Speaks Treatment Advisory Board, and also works at Arkansas Children's Hospital Research Institute, where she is the director of the Metabolic Genomics Laboratory, as well as the University of Arkansas for Medical Sciences's department of pediatrics, where she has worked since 2002.